Influenza B virus

• 

  Subject Areas on Research

  • Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection. 
  • Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus. 
  • High intensive care unit admission rate for 2013-2014 influenza is associated with a low rate of vaccination. 
  • Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. 
  • Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. 
  • Impact of a winter respiratory virus season on patients with COPD and association with influenza vaccination. 
  • Infant Antibody Repertoires during the First Two Years of Influenza Vaccination. 
  • Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study. 
  • Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? 
  • Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66. 
  • Non-lytic clearance of influenza B virus from infected cells preserves epithelial barrier function. 
  • Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season. 
  • Replication-Competent Influenza B Reporter Viruses as Tools for Screening Antivirals and Antibodies. 
  • The Development and Use of Reporter Influenza B Viruses. 
  • The Influenza B Virus Hemagglutinin Head Domain Is Less Tolerant to Transposon Mutagenesis than That of the Influenza A Virus.